Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2015 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Current Molecularly Targeting Therapies in NSCLC and Melanoma.
Anticancer Agents Med Chem. 2015;15(7):856-68. doi: 10.2174/1871520615666150202100130.
Anticancer Agents Med Chem. 2015.
PMID: 25642982
Review.
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Botting GM, Rastogi I, Chhabra G, Nlend M, Puri N.
Botting GM, et al.
PLoS One. 2015 Aug 24;10(8):e0136155. doi: 10.1371/journal.pone.0136155. eCollection 2015.
PLoS One. 2015.
PMID: 26301867
Free PMC article.
Item in Clipboard
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer.
Fong JT, Jacobs RJ, Moravec DN, Uppada SB, Botting GM, Nlend M, Puri N.
Fong JT, et al.
PLoS One. 2013 Nov 4;8(11):e78398. doi: 10.1371/journal.pone.0078398. eCollection 2013.
PLoS One. 2013.
PMID: 24223799
Free PMC article.
Item in Clipboard
Cite
Cite